Year: 2011
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: To determine the ability of clinically available volumetric MRI (vMRI) and CSF biomarkers, alone or in combination with a quantitative learning measure, to predict conversion to Alzheimer disease (AD) in patients with mild cognitive impairment (MCI). METHODS: We stratified 192 MCI participants into positive and negative risk groups on the basis of 1) degree of learning impairment on the Rey Auditory Verbal Learning Test; 2) medial temporal atrophy, quantified from Food and Drug Administration-approved software for automated vMRI analysis; and 3) CSF biomarker levels(.) We also stratified participants based on combinations of risk factors. We computed Cox proportional hazards models, controlling for age, to assess 3-year risk of converting to AD as a function of risk group and used Kaplan-Meier analyses to determine median survival times. RESULTS: When risk factors were examined separately, individuals testing positive showed significantly higher risk of converting to AD than individuals testing negative (hazard ratios [HR] 1.8-4.1). The joint presence of any 2 risk factors substantially increased risk, with the combination of greater learning impairment and increased atrophy associated with highest risk (HR 29.0): 85% of patients with both risk factors converted to AD within 3 years, vs 5% of those with neither. The presence of medial temporal atrophy was associated with shortest median dementia-free survival (15 months). CONCLUSIONS: Incorporating quantitative assessment of learning ability along with vMRI or CSF biomarkers in the clinical workup of MCI can provide critical information on risk of imminent conversion to AD.
Source: Neurology
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: UC Davis Alzheimer's Disease Core Center, G2481881534, Biomarkers in Early Alzheimer's Disease (AD)., "MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies", Structure and Functional Imaging of Age-Related Changes in Working Memory, MRI Progression Markers of Cognitive Decline in the Elderly, Alzheimer's Disease Neuroimaging Initiative, Kentucky Center for Clinical and Translational Science, Arizona Alzheimer's Disease Core Center, Kentucky Center for Clinical and Translational Science, Multimodal MRI Studies of Brain Structure and Function in PDD and AD, Alzheimer's Disease Cooperative Study, Kentucky Center for Clinical and Translational Science
OpenAlex ID: W2130126582
